Retatrutide is a triple-receptor agonist that targets GIP, GLP-1, and glucagon receptors, making it a particularly powerful option for weight management and metabolic health
Approved in 1964 for the management of hypertension, propranolol is now used for a wide range of cardiovascular diseases, including ischemic heart disease, angina pectoris, arrhythmias, and myocardial infarction, as well as non cardiovascular conditions, including migraine, tremors and anxiety
No insurance policy denial can delay PlexusDx treatment initiation, and no surprise bills arrive after therapy begins, because transparent monthly pricing replaces insurance uncertainty
For this analysis, we studied 14,210 subscribers who tracked their weight at weeks 4, 8, 16, and 40
Curry, S., Mandelkow, H., Brick, P